Satapati et al. and Surapaneni et al. reported that ROS, SOD, and MDA levels were changed during nonalcoholic fatty liver disease (NAFLD) [26, 27]. Here, SOD1 is linked to metabolic dysfunction-associated steatotic liver disease.